The Rising Cost of Chronic Diseases and What You Must Do About It
According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 90% of the nation’s $3.3 trillion in annual health care expenditure is for people with chronic and mental health conditions. That is an astronomical number and a complex issue to wrangle with, but it is also at the heart of providing value-based care in order to improve outcomes and bring down costs.
In order to understand disease prevalence and their underlying causes, and ultimately uncover clinical improvement opportunities, you need a longitudinal view of your patients and an easy way to define and segment your patient cohorts, and to run analyses – both retrospective and prospective. However, running cohort analyses can be extremely time consuming and expensive.
- Plan market launch and pricing of therapies
- Identify influential providers managing the care of patients
- Track real world use and effects of drugs
- Investigate the care of key patient populations
- Track the effectiveness of care models on patient outcomes and costs
- Understand patients comprising a market
- Plan products tailored for population sub-groups
- Track the effectiveness and utilization of new therapies
- Identify new markets of expansion
Track changes in the size of a population of interest over time and dive into their demographic characteristics.
Understand prevalence of other conditions in your designed population with breakdown by demographics to explore variation.
Cohort Performance and Utilization
Answer questions around medication share, procedures utilized, and providers engaged. Dashboards provide spend breakdowns over the patient’s longitudinal history of care.
View cost trends over time, indexed to an event of interest such as date of diagnosis.